CD4-targeted therapy and CD28-B7 costimulatory blockage may independently induce tolerance in sensitized allograft recipients

Transplant Proc. 1998 Jun;30(4):1063-4. doi: 10.1016/s0041-1345(98)00152-3.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Abatacept
  • Acute Disease
  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Antigens, CD
  • Antigens, Differentiation / therapeutic use*
  • B7-1 Antigen / immunology*
  • CD28 Antigens / immunology*
  • CD4 Antigens / immunology*
  • CTLA-4 Antigen
  • Graft Rejection / prevention & control*
  • Heart Transplantation / immunology*
  • Immunoconjugates*
  • Immunoglobulin Fc Fragments / immunology
  • Immunoglobulin G / immunology
  • Immunoglobulin M / immunology
  • Immunosuppression Therapy / methods*
  • Immunosuppressive Agents / therapeutic use*
  • Rats
  • Rats, Inbred BN
  • Rats, Inbred Lew
  • Skin Transplantation / immunology*
  • Time Factors
  • Transplantation, Homologous

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, Differentiation
  • B7-1 Antigen
  • CD28 Antigens
  • CD4 Antigens
  • CTLA-4 Antigen
  • Immunoconjugates
  • Immunoglobulin Fc Fragments
  • Immunoglobulin G
  • Immunoglobulin M
  • Immunosuppressive Agents
  • Abatacept